KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Costar (CSGP) Research & Development (2016 - 2025)

Costar (CSGP) has disclosed Research & Development for 15 consecutive years, with $109.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Research & Development rose 31.33% to $109.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $406.0 million, a 24.54% increase, with the full-year FY2025 number at $406.0 million, up 24.54% from a year prior.
  • Research & Development was $109.0 million for Q4 2025 at Costar, up from $105.4 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $109.0 million in Q4 2025 to a low of $46.8 million in Q1 2021.
  • A 5-year average of $71.1 million and a median of $67.2 million in 2023 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: rose 6.21% in 2022, then skyrocketed 31.33% in 2025.
  • Costar's Research & Development stood at $52.5 million in 2021, then rose by 11.2% to $58.4 million in 2022, then grew by 20.25% to $70.2 million in 2023, then increased by 18.23% to $83.0 million in 2024, then soared by 31.33% to $109.0 million in 2025.
  • Per Business Quant, the three most recent readings for CSGP's Research & Development are $109.0 million (Q4 2025), $105.4 million (Q3 2025), and $97.1 million (Q2 2025).